Skip to Content

EP225 (Ephed asthma ephedrine hydrochloride 25 mg / guaifenesin 200 mg)

Pill imprint EP225 has been identified as Ephed asthma ephedrine hydrochloride 25 mg / guaifenesin 200 mg.

Ephedrine/guaifenesin is used in the treatment of cold symptoms and belongs to the drug class upper respiratory combinations. FDA has not classified the drug for risk during pregnancy. Ephedrine/guaifenesin ephedrine hydrochloride 25 mg / guaifenesin 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ephed asthma
Imprint:
EP225
Strength:
ephedrine hydrochloride 25 mg / guaifenesin 200 mg
Color:
White
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Dickey Consumer Products

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide